Observations on the use of allopurinol in combination with azathioprine or mercaptopurine [1]

Alimentary Pharmacology and Therapeutics

Volumn 22, Issue 11-12, 2005, Pages 1161-1162

  Duley, J A ^a   Chocair, P R ^b   Florin, T H J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE OXIDASE; ALLOPURINOL; AZATHIOPRINE; MERCAPTOPURINE; ORNITHINE CARBAMOYLTRANSFERASE; THIOPURINE METHYLTRANSFERASE; XANTHINE OXIDASE;

APOPTOSIS; CELL FREE SYSTEM; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; DRUG ACCUMULATION; DRUG DOSE REDUCTION; DRUG POTENTIATION; ENTERITIS; ENZYME DEFICIENCY; ENZYME INACTIVATION; HUMAN; KIDNEY GRAFT; LETTER; LIVER CELL CULTURE; LIVER MITOCHONDRION; LIVER TOXICITY; MITOCHONDRION SWELLING; PRIORITY JOURNAL;

6-MERCAPTOPURINE; ALLOPURINOL; ANTIMETABOLITES; AZATHIOPRINE; DRUG COMBINATIONS; DRUG SYNERGISM; HUMANS; INFLAMMATORY BOWEL DISEASES; THIOGUANINE;

EID: 28844490574     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02703.x     Document Type: Letter

References (11)

1. Sparrow M, Hande S, Friedman S, et al. Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine. Aliment Pharmacol Ther 2005; 22: 441-6.
2. Chocair PJD, Simmonds HA, Cameron JS, et al. Low-dose allopurinol plus azathioprine/cyclosporin/prednisolone, a novel immunosuppressive regimen. Lancet 1993; 342: 83-4.
3. Duley JA, Florin TH. Thiopurine therapies: problems, complexities, and progress with monitoring thioguanine nucleotides. Ther Drug Monit 2005; 27: 647-54.
4. EBPG Expert Group on Renal Transplantation. European Best Practice Guidelines for Renal Transplantation: Section IV. Long-term management of the transplant recipient. Nephrol Dial Transplant 2002; 17: 1-67.
5. Weinshilboum RM, Raymond FA, Pazmino PA. Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties. Clin Chim Acta 1978; 85: 323-33.
6. Chocair PR, Duley JA, Simmonds HA, Cameron JS. The importance of thiopurine methyltransferase activity for the use of azathioprine in transplant recipients. Transplantation 1992; 53: 1051-6.
7. Krenitsky TA, Elion GB, Strelitz RA, Hitchings GH. Ribonucleosides of allopurinol and oxoallopurinol. Isolation from human urine, enzymatic synthesis, and characterization. J Biol Chem 1967; 242: 2675-82.
8. Duley JA, Harris O, Holmes RS. Analysis of human alcohol-and aldehyde-metabolizing isozymes by electrophoresis and isoelectric focusing. Alcohol Clin Exp Res 1985; 9: 263-71.
9. Sebesta I, Fairbanks LD, Davies PM, Simmonds HA, Leonard JV. The allopurinol loading test for identification of carriers for ornithine carbamoyl transferase deficiency: studies in a healthy control population and females at risk. Clin Chim Acta 1994; 224: 45-54.
10. Dubinsky MC, Yang H, Hassard PV, et al. 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease. Gastroenterology 2002; 122: 904-15.
11. Tapner MJ, Jones BE, Wu WM, Farrell GC. Toxicity of low dose azathioprine and 6-mercaptopurine in rat hepatocytes. Roles of xanthine oxidase and mitochondrial injury. J Hepatol 2004; 40: 454-63.